Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Medium RiskCPSC
Medications & Supplements/Prescription Drugs

Dr. Reddy's Recalls Prescription Drug Blister Packages Due to Risk of Poisoning

Agency Publication Date: February 25, 2021
Share:
Sign in to monitor this recall

Summary

Dr. Reddy's Laboratories has recalled approximately 21,400 blister packages of various prescription medications due to non-child-resistant packaging that poses a poisoning risk to young children. The recalled medications include Imatinib Mesylate, Pregabalin, Sevelamer Carbonate, and Tadalafil in various strengths. Consumers should check the packaging for the brand name, strength, lot number, and expiration date to determine if their product is affected, as listed in the Affected Products section. Consumers are advised to store these medications in a safe location out of reach of children and contact Dr. Reddy's for a full refund as part of Your Remedy Options.

Risk

The product packaging is not child-resistant, meaning young children could easily open the blisters and swallow the medication, which poses a serious risk of poisoning. No incidents or injuries have been reported to date.

What You Should Do

  1. Immediately move all recalled prescription medications to a secure, locked location that is completely out of the reach and sight of children.
  2. Check your medication packaging against the details in the Affected Products section to identify if your specific strength and lot number are part of this recall.
  3. Contact Dr. Reddy's to request a full refund for the recalled product.
  4. For additional questions or assistance, contact the CPSC Hotline at 800-638-2772.

Your Remedy Options

💰Full Refund

Consumers should immediately store the recalled medications in a safe location out of reach of children and contact Dr. Reddy's for a full refund.

Contact: Dr. Reddy's toll-free at 888-375-3784 from 8 a.m. to 8 p.m. ET Monday through Friday, or online at www.drreddys.com and click on "Recall" for more information. Report incidents related to children accessing or ingesting these prescription medications to www.SaferProducts.gov. Report adverse events, medication errors, and quality problems related to the use of these products to FDA's MedWatch Adverse Event Reporting Program either online at www.fda.gov/medwatch/report.htm, download the form at www.fda.gov/MedWatch/getforms.htm or call 800-332-1088 to request a reporting form, then complete and submit by regular mail, and return to the address on the pre-addressed form, or submit by fax to 800-FDA-0178.

Affected Products

Product: Imatinib Mesylate Tablets 100 mg
Model:
43598-344-31
Lot Numbers:
H2000138 (Exp 2022-0630)
Product: Imatinib Mesylate Tablets 400 mg
Model:
43598-345-31
Lot Numbers:
H2000127 (Exp 2022-0630)
Product: Pregabalin Capsules 50 mg
Model:
43598-292-66
Lot Numbers:
T900876 (Exp 2021-0630)
Product: Pregabalin Capsules 75 mg
Model:
43598-293-66
Lot Numbers:
T901021 (Exp 2021-0731)
Product: Pregabalin Capsules 100 mg
Model:
43598-294-66
Lot Numbers:
T901022 (Exp 2021-0731)
Product: Pregabalin Capsules 150 mg
Model:
43598-295-66
Lot Numbers:
T901023 (Exp 2021-0731)
Product: Sevelamer Carbonate Tablets 800 mg
Model:
55111-789-11
Lot Numbers:
T801003 (Exp 2020-1031)
T000009 (Exp 2021-1231)
T900221 (Exp 2021-0228)
Product: Tadalafil Tablets 5 mg
Model:
43598-575-31
Lot Numbers:
T000376 (Exp 2022-0131)
Product: Tadalafil Tablets 20 mg
Model:
43598-573-31
Lot Numbers:
T000425 (Exp 2022-0228)

Product Images

Recalled Dr. Reddy's Imatinib Mesylate Tablets 100 mg

Recalled Dr. Reddy's Imatinib Mesylate Tablets 100 mg

Recalled Dr. Reddy's Imatinib Mesylate Tablets 100 mg

Recalled Dr. Reddy's Imatinib Mesylate Tablets 100 mg

Recalled Dr. Reddy's Imatinib Mesylate Tablets 400 mg

Recalled Dr. Reddy's Imatinib Mesylate Tablets 400 mg

Recalled Dr. Reddy's Imatinib Mesylate Tablets 400 mg

Recalled Dr. Reddy's Imatinib Mesylate Tablets 400 mg

Recalled Dr. Reddy's Pregabalin Capsules 50 mg

Recalled Dr. Reddy's Pregabalin Capsules 50 mg

Recalled Dr. Reddy's Pregabalin Capsules 50 mg

Recalled Dr. Reddy's Pregabalin Capsules 50 mg

Recalled Dr. Reddy's Pregabalin Capsules 75 mg

Recalled Dr. Reddy's Pregabalin Capsules 75 mg

Recalled Dr. Reddy's Pregabalin Capsules 75 mg

Recalled Dr. Reddy's Pregabalin Capsules 75 mg

Recalled Dr. Reddy's Pregabalin Capsules 100 mg

Recalled Dr. Reddy's Pregabalin Capsules 100 mg

Recalled Dr. Reddy's Pregabalin Capsules 100 mg

Recalled Dr. Reddy's Pregabalin Capsules 100 mg

Recalled Dr. Reddy's Pregabalin Capsules 150 mg

Recalled Dr. Reddy's Pregabalin Capsules 150 mg

Recalled Dr. Reddy's Sevelamer Carbonate Tablets 800 mg

Recalled Dr. Reddy's Sevelamer Carbonate Tablets 800 mg

Recalled Dr. Reddy's Sevelamer Carbonate Tablets 800 mg

Recalled Dr. Reddy's Sevelamer Carbonate Tablets 800 mg

Recalled Dr. Reddy's Tadalafil Tablets 5 mg

Recalled Dr. Reddy's Tadalafil Tablets 5 mg

Recalled Dr. Reddy's Tadalafil Tablets 5 mg

Recalled Dr. Reddy's Tadalafil Tablets 5 mg

Recalled Dr. Reddy's Tadalafil Tablets 20 mg

Recalled Dr. Reddy's Tadalafil Tablets 20 mg

Recalled Dr. Reddy's Tadalafil Tablets 20 mg

Recalled Dr. Reddy's Tadalafil Tablets 20 mg

Additional Information

Agency: Consumer Product Safety Commission (CPSC)
Recall ID: 21089
Status: Active
Manufacturer: Dr. Reddy's Laboratories, Ltd., of India
Sold By: Beginning in 2018, Dr. Reddy's sold the recalled medications to wholesalers. Ultimately, these medications could have been sold to consumers at retail pharmacies in the United States at prices varying based on quantities prescribed, health insurance terms, and other factors.
Manufactured In: India
Units Affected: About 21,400
Distributed To: Nationwide
Importer: Dr. Reddy's Laboratories, Inc., of Princeton, N.J.
Contact: Dr. Reddy's toll-free at 888-375-3784 from 8 a.m. to 8 p.m. ET Monday through Friday, or online at www.drreddys.com and click on "Recall" for more information. Report incidents related to children accessing or ingesting these prescription medications to www.SaferProducts.gov. Report adverse events, medication errors, and quality problems related to the use of these products to FDA's MedWatch Adverse Event Reporting Program either online at www.fda.gov/medwatch/report.htm, download the form at www.fda.gov/MedWatch/getforms.htm or call 800-332-1088 to request a reporting form, then complete and submit by regular mail, and return to the address on the pre-addressed form, or submit by fax to 800-FDA-0178.
Agency Last Updated: February 25, 2021

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: CPSC Notice · Raw API Response